Private Market View

Examedi

Santiago, Chile · Founded 2021 · Privately Held (backing)

Last price · $/share
—
Implied valuation
$17.0M
Total raised
$20.7M
Last round
—

Key facts

  • Examedi’s last known valuation is $17.0M (Jan 2026).
  • It has raised $20.7M; the latest was Early Stage VC ($750K) in Jan 2026.
  • Notable investors include Y Combinator, FJ Labs, General Catalyst, Soma Capital, 8VC — 16 tracked in total.
  • 2 investment vehicles were formed to buy Examedi shares in the last 12 months, reporting $174K sold to 45 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 16 names
  • ·Watchlist + deal alerts for Examedi
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Examedi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 2 investment vehicles were formed to buy Examedi shares, reporting $174K sold to 45 investors across 2 sponsors. Most recent filing Mar 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 2 vehicles →
Companies with the most vehicle activity →

About Examedi

Operator of a telemedicine platform intended to book diagnostic tests and examinations. The company's platform connects independent medical staff with patients who need to perform their tests at home with a focus on blood tests, pregnancy, general checkups, and COVID tests, enabling patients to have access to various tests at affordable prices.

Sector
Healthcare
HQ
Santiago, Chile
Founded
2021
Employees
26
Ownership
Privately Held (backing)
PA Mark — not yet priced

Examedi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Examedi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Examedi in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.